Show simple item record

dc.contributor.authorArmañanzas, R. 
dc.contributor.authorDiaz, A. 
dc.contributor.authorMartinez, M.
dc.contributor.authorMazuelas, S. 
dc.date.accessioned2022-03-09T08:40:11Z
dc.date.available2022-03-09T08:40:11Z
dc.date.issued2022-01-14
dc.identifier.isbn978-1-6654-0126-5
dc.identifier.urihttp://hdl.handle.net/20.500.11824/1446
dc.description.abstractThe overall global death rate for COVID-19 patients has escalated to 2.13% after more than a year of worldwide spread. Despite strong research on the infection pathogenesis, the molecular mechanisms involved in a fatal course are still poorly understood.Machine learning constitutes a perfect tool to develop algorithms for predicting a patient’s hospitalization outcome at triage. This paper presents a probabilistic model, referred to as a mortality risk indicator, able to assess the risk of a fatal outcome for new patients. The derivation of the model was done over a database of 2,547 patients from the first COVID-19 wave in Spain. Model learning was tackled through a five multistart configuration that guaranteed good generalization power and low variance error estimators. The training algorithm made use of a class weighting correction to account for the mortality class imbalance and two regularization learners, logistic and lasso regressors. Outcome probabilities were adjusted to obtain cost-sensitive predictions by minimizing the type II error. Our mortality indicator returns both a binary outcome and a threestage mortality risk level. The estimated AUC across multistarts reaches an average of 0.907. At the optimal cutoff for the binary outcome, the model attains an average sensitivity of 0.898, with a 0.745 specificity. An independent set of 121 patients later released from the same consortium attained perfect sensitivity (1), with a 0.759 specificity when predicted by our model. Best performance for the indicator is achieved when the prediction’s time horizon is within two weeks since admission to hospital. In addition to a strong predictive performance, the set of selected features highlights the relevance of several underrated molecules in COVID-19 research, such as blood eosinophils, bilirubin, and urea levels.en_US
dc.description.sponsorshipAXA Research Fund project "Early prognosis of COVID-19 infections via machine learning" Basque Government special funding on Mathematical Modelling Applied to Healthen_US
dc.formatapplication/pdfen_US
dc.language.isoengen_US
dc.rightsReconocimiento-NoComercial-CompartirIgual 3.0 Españaen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/es/en_US
dc.subjectCOVID-19, Cost-Sensitive Prognosis, Clinical Indicator, Multistart Estimationen_US
dc.titleDerivation of a Cost-Sensitive COVID-19 Mortality Risk Indicator Using a Multistart Frameworken_US
dc.typeinfo:eu-repo/semantics/conferenceObjecten_US
dc.identifier.doi10.1109/BIBM52615.2021.9669288en_US
dc.relation.publisherversionhttps://ieeexplore.ieee.org/document/9669288en_US
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessen_US
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersionen_US
dc.journal.title2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Reconocimiento-NoComercial-CompartirIgual 3.0 España
Except where otherwise noted, this item's license is described as Reconocimiento-NoComercial-CompartirIgual 3.0 España